|
Disclosures: Honoraria- Mashup Media (Relationship has ended)|Consulting Fee- Mashup Media (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Honoraria-Bristol-Myers Squibb Company|Consulting Fee-AbbVie Inc.|Honoraria-AbbVie Inc.|Consulting Fee-Genentech, Inc.|Honoraria-Genentech, Inc.|Grant or research support-Genmab|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-FL Cures Foundation|Membership on Advisory Committees or Review Panels, Board Membership, etc.-American Society of Hematology - 07/10/2024
Dr. Carla Casulo is an Associate Professor of Medicine, and Assistant Director of Cancer Research Training and Education at the Wilmot Cancer Institute. Dr. Casulo is an international expert and clinician-researcher in lymphoma, best known for her pivotal work in follicular lymphoma. She also has an expertise and passion for young adults with Hodgkin and Non-Hodgkin lymphoma. Dr. Casulo’s research focuses on identifying risk and individual prognosis to address patient's treatment needs and sequence of therapy using a precision approach. Dr. Casulo uses real world, large patient datasets and clinical trials to discover patterns of therapy, new treatments, and ways to improve survival for patients with lymphoma. Dr. Casulo is a member of ASH, ASCO, and the LEO Consortium. She was a Scholar in the LRF LSRMP class of 2015 and is now a faculty member. She is a Steering Committee Member and Chair of the Women in Lymphoma Global Organization.
|